Latest Schedule 13G passive stakes

NASDAQ
FMR LLC and Abigail P. Johnson have reported a beneficial ownership of 7.0% in Brightspring Health Services Inc. as of June 30, 2026.
NYSE
FMR LLC and Abigail P. Johnson have reported beneficial ownership of 7.0% of BULLISH's common stock as of June 30, 2026.
NYSE
FMR LLC and Abigail P. Johnson have reported beneficial ownership of 7,407,690 shares, representing 5.7% of the outstanding common stock of Bob's Discount Furniture Inc.
NASDAQ
FMR LLC and Abigail P. Johnson have reported beneficial ownership of 5.6% of Boost Run Inc.'s Class A Common Stock as of June 30, 2026.
NASDAQ
FMR LLC and Abigail P. Johnson have jointly filed a Schedule 13G, reporting beneficial ownership of 7.7% of CECO Environmental Corp's common stock as of June 30, 2026.
NYSE
FMR LLC and Abigail P. Johnson have reported a combined beneficial ownership of 5.7% in Clean Harbors Inc. common stock as of June 30, 2026.
NYSE
FMR LLC and Abigail P. Johnson have jointly filed a Schedule 13G, disclosing beneficial ownership of 4,239,751.47 shares, representing 8.8% of Charles River Laboratories International, Inc.'s common stock as of June 30, 2026.
NASDAQ
FMR LLC and Abigail P. Johnson have jointly filed a Schedule 13G, disclosing a beneficial ownership of 15.0% of Bruker Corp's common stock as of June 30, 2026.
NYSE
FMR LLC and Abigail P. Johnson have jointly filed a Schedule 13G, reporting beneficial ownership of 2,194,722.26 shares of Constellium SE common stock, representing 1.6% of the class.
NASDAQ
FMR LLC and Abigail P. Johnson have updated their beneficial ownership filing for Braze Inc., now reporting a 15.0% stake in the company's Class A Common Stock as of June 30, 2026.
NASDAQ
FMR LLC and Abigail P. Johnson have updated their beneficial ownership filing for Bowman Consulting Group Ltd, reporting a 13.7% stake as of June 30, 2026.
NASDAQ
FMR LLC and Abigail P. Johnson have reported a combined beneficial ownership of 15.0% of Ceribell Inc.'s common stock as of June 30, 2026.
NYSE
FMR LLC and Abigail P. Johnson have filed a Schedule 13G, reporting beneficial ownership of 4.8% of AZZ Inc.'s common stock as of June 30, 2026.
NYSE
FMR LLC and Abigail P. Johnson have reported a combined beneficial ownership of 5.7% in Amphenol Corporation's Class A Common Stock as of June 30, 2026.
NASDAQ
FMR LLC and Abigail P. Johnson have reported a combined beneficial ownership of 13.7% in Allegro Microsystems Inc. as of June 30, 2026.
NASDAQ
FMR LLC and Abigail P. Johnson have reported beneficial ownership of 3.8% of Advanced Energy Industries Inc.'s common stock as of June 30, 2026.
NYSE
FMR LLC and Abigail P. Johnson report a combined beneficial ownership of 8.2% of Abercrombie & Fitch Co.'s Class A Common Stock as of June 30, 2026.
NASDAQ
FMR LLC and Abigail P. Johnson have jointly filed a Schedule 13G, disclosing beneficial ownership of 5,015,726.57 shares, representing 5.5% of Acadia Healthcare Co Inc's common stock as of June 30, 2026.
NYSE
FMR LLC and Abigail P. Johnson have updated their Schedule 13G filing, reporting beneficial ownership of 5,316,383.48 shares, representing 6.5% of Atmus Filtration Technologies Inc.'s common stock as of June 30, 2026.
NASDAQ
FMR LLC and Abigail P. Johnson have reported beneficial ownership of 7.5% of Anteris Technologies Global Corp's common stock as of June 30, 2026.
NASDAQ
FMR LLC, through its affiliates, has disclosed beneficial ownership of 10,032,312.93 shares, representing 9.4% of Amdocs Limited's common stock as of June 30, 2026.
NASDAQ
FMR LLC, along with Abigail P. Johnson, has disclosed a beneficial ownership of 5.7% in Align Technology Inc. common stock as of June 30, 2026.
NASDAQ
FMR LLC, along with Abigail P. Johnson, has reported a beneficial ownership of 13.4% in Axcelis Technologies Inc. common stock as of June 30, 2026.
NASDAQ
FMR LLC and Abigail P. Johnson have reported a beneficial ownership of 6.5% in American Public Education Inc. as of June 30, 2026.
NYSE
FMR LLC, along with Abigail P. Johnson, has reported a beneficial ownership of 5.2% in Axos Financial's common stock as of June 30, 2026.
NASDAQ
FMR LLC and Abigail P. Johnson have jointly filed a Schedule 13G, reporting beneficial ownership of 2,471,418 shares, representing 2.5% of ATYR PHARMA INC's common stock as of June 30, 2026.
NYSE
FMR LLC and Abigail P. Johnson have jointly filed a Schedule 13G, disclosing a beneficial ownership of 5.4% of Antero Resources Corp.'s common stock as of June 30, 2026.
NASDAQ
FMR LLC and Abigail P. Johnson have reported beneficial ownership of 9.7% of Avalo Therapeutics' common stock as of June 30, 2026.
NASDAQ
FMR LLC, through its affiliates, has disclosed beneficial ownership of 11.5% of Allbirds Inc.'s Class A Common Stock as of June 30, 2026.
NASDAQ
FMR LLC and Abigail P. Johnson have jointly filed a Schedule 13G, reporting beneficial ownership of 9.6% of Almonty Industries Inc. common stock as of June 30, 2026.